# Progress of Research on the Metabolic Regulation of Lactylation in Muscle Tissues and Its Disease Associations

**Authors:** Zhihang Wang, Ji Zhang, Junxi Wu, Guangrun Liu, Yun He, Hongbo Zhao, Xiaolin Jiang, Shengbo Yang

PMC · DOI: 10.3390/biom16020212 · Biomolecules · 2026-01-30

## TL;DR

Lactylation connects metabolism and gene regulation in muscles, affecting health and disease, and could lead to new treatments for muscle disorders.

## Contribution

This paper highlights lactylation's role in muscle metabolism and disease, emphasizing its potential as a therapeutic target.

## Key findings

- Lactylation regulates myocyte energy metabolism and exercise adaptation through a dynamic mechanism.
- Aberrant lactylation contributes to insulin resistance and diabetic cardiomyopathy.
- Lactylation has dual effects in cardiovascular diseases, both protecting and aggravating injury.

## Abstract

Lactylation serves as a vital link between cellular metabolism and epigenetic regulation and plays a pivotal role in muscle biology. Muscle tissue is the primary site of lactate production; its unique metabolic environment confers dynamism, specificity and functional diversity for lactylation. Under physiological conditions, lactylation regulates myocyte energy metabolism, proliferation, differentiation, and exercise adaptation through a dynamic “writer–eraser–reader” mechanism. In pathological states, lactate imbalance directly contributes to the progression of various muscular disorders. For instance, diminished histone lactylation during muscle aging suppresses the expression of genes critical for DNA repair and protein homeostasis. Aberrant lactylation is involved in the development of insulin resistance and diabetic cardiomyopathy. Furthermore, lactylation exerts dual effects in cardiovascular diseases; it provides protection by enhancing the transcription of repair genes and simultaneously aggravates injury by promoting processes such as fibrosis and ferroptosis. Collectively, these findings underscore the importance of lactylation in muscular pathologies and provide a theoretical foundation for the development of therapies that target this modification process. As the regulatory mechanisms of lactylation have become clearer, precise interventions targeting specific modification sites are expected to open new therapeutic avenues for muscular diseases.

## Full-text entities

- **Genes:** GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, UBC (ubiquitin C) [NCBI Gene 7316] {aka HMG20}, SUCLG2 (succinate-CoA ligase GDP-forming subunit beta) [NCBI Gene 8801] {aka G-SCS, GBETA, GTPSCS}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, AADAT (aminoadipate aminotransferase) [NCBI Gene 51166] {aka KAT2, KATII, KYAT2}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, ACAT2 (acetyl-CoA acetyltransferase 2) [NCBI Gene 39], SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) [NCBI Gene 5160] {aka E1alpha, PDHA, PDHAD, PDHCE1A, PHE1A}, PHOSPHO1 (phosphoethanolamine/phosphocholine phosphatase 1) [NCBI Gene 162466], LRG1 (leucine rich alpha-2-glycoprotein 1) [NCBI Gene 116844] {aka HMFT1766, LRG}, HAGH (hydroxyacylglutathione hydrolase) [NCBI Gene 3029] {aka GLO2, GLO2D, GLX2, GLXII, HAGH1}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, TRAP1 (TNF receptor associated protein 1) [NCBI Gene 10131] {aka HSP 75, HSP75, HSP90L, TRAP-1}, YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) [NCBI Gene 51441] {aka CAHL, DF2, HGRG8, NY-REN-2}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376] {aka CPT1, CPTASE, IIAE4}, UNC5B-AS1 (UNC5B antisense RNA 1) [NCBI Gene 728978] {aka TP53LC05, UASR1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, ACLY (ATP citrate lyase) [NCBI Gene 47] {aka ACL, ATPCL, CLATP}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, KAT5 (lysine acetyltransferase 5) [NCBI Gene 10524] {aka ESA1, HTATIP, HTATIP1, NEDFASB, PLIP, TIP}, ALDOA (aldolase, fructose-bisphosphate A) [NCBI Gene 226] {aka ALDA, GSD12, HEL-S-87p}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, NEDD4 (NEDD4 E3 ubiquitin protein ligase) [NCBI Gene 4734] {aka NEDD4-1, RPF1}, BMP5 (bone morphogenetic protein 5) [NCBI Gene 653], CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, LDHA (lactate dehydrogenase A) [NCBI Gene 3939] {aka GSD11, HEL-S-133P, LDHM, PIG19}, NEU2 (neuraminidase 2) [NCBI Gene 4759] {aka SIAL2}, CHI3L1 (chitinase 3 like 1) [NCBI Gene 1116] {aka ASRT7, CGP-39, GP-39, GP39, HC-gp39, HCGP-3P}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, SMAD2 (SMAD family member 2) [NCBI Gene 4087] {aka CHTD8, JV18, JV18-1, LDS6, MADH2, MADR2}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TOP1 (DNA topoisomerase I) [NCBI Gene 7150] {aka TOPI}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, EMILIN1 (elastin microfibril interfacer 1) [NCBI Gene 11117] {aka ATBFS, EMI, EMILIN, HMN10, HMND10, gp115}, CREBBP (CREB binding lysine acetyltransferase) [NCBI Gene 1387] {aka CBP, KAT3A, MKHK1, RSTS, RSTS1}, HDAC3 (histone deacetylase 3) [NCBI Gene 8841] {aka HD3, KDAC3, RPD3, RPD3-2}, ACAA2 (acetyl-CoA acyltransferase 2) [NCBI Gene 10449] {aka DSAEC, T1}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, E2F2 (E2F transcription factor 2) [NCBI Gene 1870] {aka E2F-2}, RFC3 (replication factor C subunit 3) [NCBI Gene 5983] {aka RFC38}, ACADS (acyl-CoA dehydrogenase short chain) [NCBI Gene 35] {aka ACAD3, SCAD}, WWP1 (WW domain containing E3 ubiquitin protein ligase 1) [NCBI Gene 11059] {aka AIP5, Tiul1, hSDRP1}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, TRPC5 (transient receptor potential cation channel subfamily C member 5) [NCBI Gene 7224] {aka PPP1R159, TRP5}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** fatigue (MESH:D005221), cardiac hypertrophy (MESH:D006332), myocardial damage (MESH:D009202), Metabolic Myopathies (MESH:D009135), hypertrophic obstructive cardiomyopathy (MESH:D002312), CM (MESH:D006331), Tumorigenesis (MESH:D063646), type 2 diabetes (MESH:D003924), Heart Failure (MESH:D006333), obese (MESH:D009765), hypoxic (MESH:D002534), Pulmonary Hypertension (MESH:D006976), chronic (MESH:D002908), hypoxia (MESH:D000860), hyperlactatemia (MESH:D065906), muscle ischemia (MESH:D007511), metabolic disorder (MESH:D008659), EndMT (MESH:D008579), diabetic cardiomyopathy (MESH:D058065), cardiomyocyte death (MESH:D003643), mitochondrial damage (MESH:D028361), pulmonary arterial hypertension (MESH:D000081029), Atherosclerosis (MESH:D050197), injury (MESH:D014947), arterial calcification (MESH:D061205), cardiac inflammation (MESH:D007249), fibrosis (MESH:D005355), MIRI (MESH:D015427), coronary artery occlusion (MESH:D054059), insulin resistance (MESH:D007333), MI (MESH:D009203), Cardiovascular Diseases (MESH:D002318), hypertrophy (MESH:D006984), diabetes (MESH:D003920), Myocardial Ischemia (MESH:D017202), tumor (MESH:D009369)
- **Chemicals:** free fatty acids (MESH:D005230), 12-HEPE (MESH:C026221), lipopolysaccharide (MESH:D008070), acetyl-CoA (MESH:D000105), Lipid (MESH:D008055), glycogen (MESH:D006003), phenolic acid (MESH:C017616), Trichostatin A (MESH:C012589), amide (MESH:D000577), ATP (MESH:D000255), lactoyl-CoA (MESH:C047009), stiripentol (MESH:C021092), methylglyoxal (MESH:D011765), glutathione (MESH:D005978), metformin (MESH:D008687), nicotinamide (MESH:D009536), beta-alanine (MESH:D015091), Glucose (MESH:D005947), chlorogenic acid (MESH:D002726), malate (MESH:C030298), reactive oxygen species (MESH:D017382), TSA (MESH:C481298), lysine (MESH:D008239), NAD (MESH:D009243), vitamin C (MESH:D001205), gossypetin (MESH:C059922), suberoylanilide hydroxamic acid (MESH:D000077337), gallic acid (MESH:D005707), A-485 (-), pyruvate (MESH:D019289), curcumin (MESH:D003474), palmitate (MESH:D010168), dichloroacetate (MESH:D003999), triglycerides (MESH:D014280), 2-deoxyglucose (MESH:D003847), CoA (MESH:D003065), lonidamine (MESH:C016371), tricarboxylic acid (MESH:D014233), Lactoylglutathione (MESH:C013585), glyceraldehyde-3-phosphate (MESH:D005986), fatty acid (MESH:D005227), oxaloacetate (MESH:D062907), GSK2837808A (MESH:C000612070), L-lactate (MESH:D019344)
- **Species:** Equus caballus (domestic horse, species) [taxon 9796], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** A12A
- **Cell lines:** SKMC — Homo sapiens (Human), Transformed cell line (CVCL_VG48), EC — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U411)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937968/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937968/full.md

## References

100 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937968/full.md

---
Source: https://tomesphere.com/paper/PMC12937968